Cardiff Lexington Corp (CDIX) Form 10-Q Quarterly Reports
Cardiff Lexington Corp (CDIX) is a publicly traded company on the OTC, categorized under SIC 8011 (Services-Offices & Clinics of Doctors of Medicine). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CDIX
CIK: 811222
Exchange: OTC
SIC 8011: Services-Offices & Clinics of Doctors of Medicine
Fiscal Year End: 12/31
State: FL
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
GBQ Partners LLC
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMichael Purcell
Audit LocationColumbus, Ohio, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-24 | 2026-09-24 | FORM 8-K | 0001683168-26-007348 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-08 | 4 Filing | 0001683168-26-007167 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-08 | 4 Filing | 0001683168-26-007166 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-08 | 4 Filing | 0001683168-26-007165 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-08-31 | CURRENT REPORT | 0001683168-26-006974 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006232 | View SEC Doc Filr Page |
| 424B3 | 2026-06-23 | — | FORM 424(B)(3) | 0001683168-26-005066 | View SEC Doc Filr Page |
| EFFECT | 2026-06-18 | — | EFFECT Filing | 9999999995-26-002069 | View SEC Doc Filr Page |
| S-1 | 2026-06-11 | — | FORM S-1 | 0001683168-26-004763 | View SEC Doc Filr Page |
| S-8 | 2026-06-11 | — | FORM S-8 | 0001683168-26-004759 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-05 | FORM 8-K | 0001683168-26-004756 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q FOR MAR 2026 | 0001683168-26-003791 | View SEC Doc Filr Page |
| AW | 2026-05-12 | — | FORM AW | 0001683168-26-003738 | View SEC Doc Filr Page |
| RW | 2026-04-30 | — | FORM RW | 0001683168-26-003354 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 Filing | 0001683168-26-002660 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 Filing | 0001683168-26-002658 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 Filing | 0001683168-26-002657 | View SEC Doc Filr Page |
| POS AM | 2026-03-13 | — | POST-EFFECTIVE AMENDMENT 1 | 0001683168-26-001770 | View SEC Doc Filr Page |
| 10-K | 2026-03-10 | 2025-12-31 | FORM 10-K FOR DEC 2025 | 0001683168-26-001639 | View SEC Doc Filr Page |
| EFFECT | 2026-02-13 | — | EFFECT Filing | 9999999995-26-000571 | View SEC Doc Filr Page |
| CORRESP | 2026-02-11 | — | CORRESP Filing | 0001683168-26-000906 | View SEC Doc Filr Page |
| CORRESP | 2026-02-11 | — | CORRESP Filing | 0001683168-26-000905 | View SEC Doc Filr Page |
| CORRESP | 2026-02-10 | — | CORRESP Filing | 0001683168-26-000887 | View SEC Doc Filr Page |
| CORRESP | 2026-02-10 | — | CORRESP Filing | 0001683168-26-000886 | View SEC Doc Filr Page |
| S-1/A | 2026-02-05 | — | AMENDMENT NO .3 | 0001683168-26-000787 | View SEC Doc Filr Page |